IDEC - PDFSEARCH.IO - Document Search Engine

IDEC
Results: 499

#	Item
281	To: From: Through: Date: BLA STN[removed]NAB supplement) Add to Reading List Source URL: www.fda.gov Language: English Laboratory techniques Immunologic tests Science Assay Biochemistry Titration ELISA Interferon beta-1a Biogen Idec Chemistry Cytokines Biology
282	ALS Therapy Development Institute Adds Two Board Members Add to Reading List Source URL: www.als.net Language: English - Date: 2013-05-07 09:51:34 Health Biogen Idec James Heywood ALS Therapy Development Institute Rare diseases Amyotrophic lateral sclerosis
283	Biogen Idec and Irish Network Boston present: Does New England and contemporary Ireland have what it takes to be sustainable? A panel discussion sponsored by Biogen Idec’s Global Diversity & Inclusion Program Add to Reading List Source URL: www.bc.edu - Date: 2014-10-30 15:05:50
284	Memorandum Food and Drug Administration Center for Biologics Evaluation and Research Office of Compliance and Biologics Quality Division of Manufacturing and Product Quality Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Medicine Medical equipment Food safety Interferon beta-1a Validation Food and Drug Administration Biogen Idec Verification and validation Pharmaceutical industry Pharmaceutical sciences Validity
285	DRAFT Appeal Letter – Tecfidera TODAY’s DATE Health Plan Addressee Line 1 Health Plan Addressee Line 2 Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-09-11 11:14:36 Health Glatiramer acetate Biogen Idec Dimethyl fumarate Placebo Therapies under investigation for multiple sclerosis Corinne Goldsmith Dickinson Center for Multiple Sclerosis Medicine Multiple sclerosis Immunology
286	Interferon beta-1a, Avonex Medication Guide Add to Reading List Source URL: www.fda.gov Language: English Anatomy Interferon beta-1a Pfizer Medical equipment Syringe White blood cell Interferon Methadone Biogen Idec Biology Cytokines Medicine
287	September 13,2004 Enclosed, please find the document submitted by Dr. James Green of Biogen Idec for the Docket No. 2004N-0355/Scientific Considerations Related to Developing Follow-Biologics Protein Products. Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-04-25 18:26:37 Pharmaceutical industry Drug discovery Food and Drug Administration Biosimilar Pre-clinical development Clinical trial Biologic Immunogenicity Bioequivalence Pharmaceutical sciences Pharmacology Clinical research
288	Biogen_PressRelease_FINAL Add to Reading List Source URL: www.myelinrepair.org Language: English - Date: 2013-07-01 10:08:23 Biogen Idec Myelin Repair Foundation Demyelinating disease IDEC Anatomy Biology Multiple sclerosis Myelin Nervous system Neurons
289	Media Contact: Robert A. Goldstein, ALS TDI, [removed], [removed]FOR IMMEDIATE RELEASE ALS Therapy Development Institute Announces Research Agreement with Biogen Idec and UCB to Investigate the Role of CD40 Add to Reading List Source URL: www.als.net Language: English - Date: 2012-11-16 13:43:05 Biogen Idec Amyotrophic lateral sclerosis Motor neurone disease SOD1 IDEC Sean F. Scott Rare diseases ALS Therapy Development Institute Health
290	BLA STN[removed]Biogen Avonex, Interferon beta-la for MS) To: From: Through: Add to Reading List Source URL: www.fda.gov Language: English Medicine Immunologic tests Interferon beta-1a Pfizer Biogen Idec Interferon Immunogenicity Antibody titer Antibody Biology Cytokines Immunology

UPDATE